National Comprehensive Cancer Network | Sep 24, 2021
Four out of five cancer therapies tested in Phase III trials do not achieve meaningful benefit in prolonging survival
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.